0001415889-17-000308.txt : 20170223 0001415889-17-000308.hdr.sgml : 20170223 20170223180124 ACCESSION NUMBER: 0001415889-17-000308 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170221 FILED AS OF DATE: 20170223 DATE AS OF CHANGE: 20170223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moore Terrence O CENTRAL INDEX KEY: 0001454276 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 17633985 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC STREET 2: 3911 SORRENTO VALLEY BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 form4-02232017_030207.xml X0306 4 2017-02-21 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001454276 Moore Terrence O 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 false true false false EVP, CHIEF COMMERCIAL OFFICER Common Stock 2017-02-21 4 M 0 7856 34.45 A 9527 D Common Stock 2017-02-21 4 S 0 7856 39.65 D 1671 D Stock Option (right to buy) 34.45 2017-02-21 4 M 0 7856 0 D 2025-03-19 Common Stock 7856 82500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016. All sales under the trading plan have been completed. 25% of the shares subject to the Stock Option vested and became exercisable on March 20, 2016. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. /s/ Elizabeth Carter, Attorney-in-Fact 2017-02-23